Thorsten Jumpertz

1.0k total citations
17 papers, 861 citations indexed

About

Thorsten Jumpertz is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Thorsten Jumpertz has authored 17 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Physiology and 5 papers in Oncology. Recurrent topics in Thorsten Jumpertz's work include Alzheimer's disease research and treatments (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Antibiotic Resistance in Bacteria (5 papers). Thorsten Jumpertz is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Drug Transport and Resistance Mechanisms (5 papers) and Antibiotic Resistance in Bacteria (5 papers). Thorsten Jumpertz collaborates with scholars based in Germany, France and Switzerland. Thorsten Jumpertz's co-authors include Lutz Schmitt, I.B. Holland, Stefan Jenewein, Jelena Zaitseva, Sascha Weggen, Claus U. Pietrzik, Christine Oswald, Christoph Becker‐Pauly, Mirsada Čaušević and Alexander Wiedenmann and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and PLoS ONE.

In The Last Decade

Thorsten Jumpertz

17 papers receiving 853 citations

Peers

Countries citing papers authored by Thorsten Jumpertz

Since Specialization

Citations

This map shows the geographic impact of Thorsten Jumpertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Jumpertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Jumpertz more than expected).

Fields of papers citing papers by Thorsten Jumpertz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thorsten Jumpertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Jumpertz. The network helps show where Thorsten Jumpertz may publish in the future.

Co-authorship network of co-authors of Thorsten Jumpertz

This figure shows the co-authorship network connecting the top 25 collaborators of Thorsten Jumpertz. A scholar is included among the top collaborators of Thorsten Jumpertz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thorsten Jumpertz. Thorsten Jumpertz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Discovery and validation of 2-styryl substituted benzoxazin-4-ones as a novel scaffold for rhomboid protease inhibitors 2018 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Thorsten Jumpertz, (unknown), Isabella Ogorek, David C. Mikles, Martin Hubálek, Claus U. Pietrzik, Kvido Střı́šovský, Boris Schmidt, Sascha Weggen	16
2	The metalloprotease ADAMTS4 generates N-truncated Aβ4–x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer’s disease 2018 ·Acta Neuropathologica ·Susanne Walter, Thorsten Jumpertz, Melanie Hüttenrauch, Isabella Ogorek, (unknown), Steffen E. Storck, Silvia Zampar, Mitko Dimitrov, (unknown), Klaudia Lepka, Carsten Berndt, Jens Wiltfang, Christoph Becker‐Pauly, Dirk Beher, Claus U. Pietrzik, Patrick C. Fraering, Oliver Wirths, Sascha Weggen	45
3	Discovery and Biological Evaluation of Potent and Selective N-Methylene Saccharin-Derived Inhibitors for Rhomboid Intramembrane Proteases 2017 ·Biochemistry ·(unknown), Thorsten Jumpertz, David C. Mikles, (unknown), Minh Tú Nguyễn, Steven H. L. Verhelst, Martin Hubálek, Darren C. Johnson, Daniel A. Bachovchin, Isabella Ogorek, Claus U. Pietrzik, Kvido Střı́šovský, Boris Schmidt, Sascha Weggen	12
4	The Metalloprotease Meprin β Generates Amino Terminal-truncated Amyloid β Peptide Species 2012 ·Journal of Biological Chemistry ·(unknown), (unknown), Mirsada Čaušević, Thorsten Jumpertz, Lisa Marie Munter, Gerd Multhaup, Sascha Weggen, Christoph Becker‐Pauly, Claus U. Pietrzik	107
5	Presenilin Is the Molecular Target of Acidic γ-Secretase Modulators in Living Cells 2012 ·PLoS ONE ·Thorsten Jumpertz, Andreas Rennhack, (unknown), Sandra Baches, Claus U. Pietrzik, Bruno Bulic, Sascha Weggen	36
6	Synthesis of a potent photoreactive acidic γ-secretase modulator for target identification in cells 2012 ·Bioorganic & Medicinal Chemistry ·Andreas Rennhack, Thorsten Jumpertz, (unknown), Sandra Baches, Claus U. Pietrzik, Sascha Weggen, Bruno Bulic	10
7	Discovery of γ-Secretase Modulators with a Novel Activity Profile by Text-Based Virtual Screening 2012 ·ACS Chemical Biology ·Heiko Zettl, (unknown), Volker Hähnke, Dirk Beher, Thorsten Jumpertz, (unknown), Karlheinz Baumann, Claus U. Pietrzik, Bruno Bulic, Gisbert Schneider, Sascha Weggen	4
8	O2‐04‐04: The metalloprotease meprin beta generates amino‐terminally truncated beta‐amyloid peptide species 2012 ·Alzheimer s & Dementia ·(unknown), (unknown), Mirsada Čaušević, Thorsten Jumpertz, Lisa Marie Munter, Gerd Multhaup, Sascha Weggen, Christoph Becker‐Pauly, Claus U. Pietrzik	2
9	Crystallization and preliminary X-ray crystallographic studies of an oligomeric species of a refolded C39 peptidase-like domain of theEscherichia coliABC transporter haemolysin B 2011 ·Acta Crystallographica Section F Structural Biology and Crystallization Communications ·Christian Schwarz, (unknown), Thorsten Jumpertz, Stefan Jenewein, Justin Lecher, Dieter Willbold, Santosh Panjikar, I. Barry Holland, Sander H. J. Smits, Lutz Schmitt	2
10	Chemical Biology, Molecular Mechanism and Clinical Perspective of γ - Secretase Modulators in Alzheimers Disease 2011 ·Current Neuropharmacology ·Bruno Bulic, (unknown), Stefanie Hahn, Andreas Rennhack, Thorsten Jumpertz, Sascha Weggen	35
11	Metalloprotease Meprin β Generates Nontoxic N-terminal Amyloid Precursor Protein Fragments in Vivo 2011 ·Journal of Biological Chemistry ·(unknown), Mirsada Čaušević, Ulrich auf dem Keller, Oliver Schilling, (unknown), (unknown), (unknown), (unknown), Thorsten Jumpertz, Sascha Weggen, Judith Bond, Christopher M. Overall, Claus U. Pietrzik, Christoph Becker‐Pauly	77
12	High-throughput evaluation of the critical micelle concentration of detergents 2010 ·Analytical Biochemistry ·Thorsten Jumpertz, (unknown), (unknown), Sander H. J. Smits, Robert Ernst, Lutz Schmitt	40
13	Mutations affecting the extreme C terminus of Escherichia coli haemolysin A reduce haemolytic activity by altering the folding of the toxin 2010 ·Microbiology ·Thorsten Jumpertz, Christian Chervaux, Kathleen I. Racher, (unknown), Mark A. Blight, I. Barry Holland, Lutz Schmitt	10
14	A structural analysis of asymmetry required for catalytic activity of an ABC‐ATPase domain dimer 2006 ·The EMBO Journal ·Jelena Zaitseva, Christine Oswald, Thorsten Jumpertz, Stefan Jenewein, Alexander Wiedenmann, I.B. Holland, Lutz Schmitt	127
15	A molecular understanding of the catalytic cycle of the nucleotide-binding domain of the ABC transporter HlyB 2005 ·Biochemical Society Transactions ·Stefan Jenewein, Jelena Zaitseva, Christine Oswald, Thorsten Jumpertz, I.B. Holland, Lutz Schmitt	29
16	H662 is the linchpin of ATP hydrolysis in the nucleotide‐binding domain of the ABC transporter HlyB 2005 ·The EMBO Journal ·Jelena Zaitseva, Stefan Jenewein, Thorsten Jumpertz, I.B. Holland, Lutz Schmitt	286
17	A molecular understanding of the catalytic cycle of the nucleotide-binding domain of the ABC transporter HlyB 2005 ·Biochemical Society Transactions ·Jelena Zaitseva, Stefan Jenewein, Christine Oswald, Thorsten Jumpertz, I.B. Holland, Lutz Schmitt	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact